Longitudinal follow up of dysglycemia in overweight and obese pediatric patients

Pediatr Diabetes. 2018 Mar;19(2):199-204. doi: 10.1111/pedi.12570. Epub 2017 Aug 30.

Abstract

Objective: To examine factors related to progression of dysglycemia in overweight and obese youth in a large primary care setting.

Research design and methods: 10- to 18-year-old youth with body mass index (BMI) > 85 percentile and first-time A1c 5.7%-7.9% (39-63 mmol/mol) were identified retrospectively through electronic medical records (EMR). Levels of dysglycemia were defined as low-range prediabetes (LRPD; A1c 5.7%-5.9% [39-41 mmol/mol]), high-range prediabetes (HRPD; A1c 6.0%-6.4% [42-46 mmol/mol]), or diabetes-range (A1c 6.5%-7.9% [48 mmol/mol]). Follow-up A1c and BMI were extracted from the EMR. Follow up was truncated at the time of initiation of diabetes medication.

Results: Of 11 000 youth, 547 were identified with baseline dysglycemia (mean age 14.5 ± 2.2 years, 70% Hispanic, 23% non-Hispanic Black, 7% other). Of these, 206 had LRPD, 282 HRPD, and 59 diabetes. Follow-up A1c was available in 420 (77%), with median follow up of 12-22 months depending on A1c category. At follow-up testing, the percent with diabetes-range A1c was 4% in youth with baseline LRPD, 8% in youth with baseline HRPD, and 33% in youth with baseline diabetes-range A1c. There was a linear association between BMI increase and worsening A1c for LRPD (P < .001) and HRPD (P = .003).

Conclusions: Most adolescents with an initial prediabetes or diabetes-range A1c did not have a diabetes-range A1c on follow up. Moreover, prediabetes-range A1c values do not all convey equal risk for the development of diabetes, with lower rates of progression for youth with initial A1c <6%. In youth with prediabetes-range A1c, BMI stabilization was associated with improvement of glycemia.

Keywords: community health; dysglycemia; obesity; prediabetes; youth.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Body Mass Index
  • Child
  • Colorado / epidemiology
  • Delivery of Health Care, Integrated
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Disease Progression
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Incidence
  • Longitudinal Studies
  • Male
  • Overweight / complications
  • Overweight / therapy*
  • Pediatric Obesity / complications
  • Pediatric Obesity / therapy*
  • Prediabetic State / blood
  • Prediabetic State / complications*
  • Prediabetic State / epidemiology
  • Prediabetic State / physiopathology
  • Prevalence
  • Retrospective Studies
  • Risk
  • Weight Gain
  • Weight Loss
  • Weight Reduction Programs*

Substances

  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human